CPIX
Cumberland Pharmaceuticals Inc
NASDAQ: CPIX · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$4.19
-0.48% today
Updated 2026-04-30
Market cap
$60.72M
P/E ratio
—
P/S ratio
1.36x
EPS (TTM)
$-0.19
Dividend yield
—
52W range
$2 – $6
Volume
1.2M
Cumberland Pharmaceuticals Inc (CPIX) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
0 of 8
Last 8 quarters
Avg EPS surprise
—
Last 4 quarters
Revenue YoY growth
+31.1%
Most recent quarter
EPS YoY growth
+30.7%
Most recent quarter
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-12.6%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-15.6%
2025-11-04
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-10 | $-0.09 | — | $3.41 | $3.08 | -9.7% |
| 2025-11-04 | $-0.13 | — | $2.76 | $2.33 | -15.6% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $0.00 | $-0.09 | — | $13.68M | +31.1% |
| 2025-09-30 | $0.00 | $-0.13 | — | $8.29M | -8.7% |
| 2025-06-30 | $0.00 | $-0.05 | — | $10.84M | +10.0% |
| 2025-03-31 | — | $0.08 | — | $11.71M | +37.8% |
| 2024-12-31 | — | $-0.14 | — | $10.44M | +11.6% |
| 2024-09-30 | — | $-0.11 | — | $9.09M | -9.9% |
| 2024-06-30 | — | $-0.08 | — | $9.85M | -9.6% |
| 2024-03-31 | — | $-0.14 | — | $8.50M | -7.9% |
| 2023-12-31 | — | $-0.44 | — | $9.35M | — |
| 2023-09-30 | — | $0.02 | — | $10.09M | — |
| 2023-06-30 | — | $0.16 | — | $10.89M | — |
| 2023-03-31 | — | $0.11 | — | $9.22M | — |
Frequently asked questions
Has Cumberland Pharmaceuticals Inc beaten earnings estimates?
Cumberland Pharmaceuticals Inc has beaten Wall Street EPS estimates in 0 of its last 8 quarterly reports.
How does CPIX stock react to earnings?
CPIX stock has moved an average of -12.6% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.
What is Cumberland Pharmaceuticals Inc's revenue growth rate?
Cumberland Pharmaceuticals Inc reported year-over-year revenue growth of +31.1% in its most recent quarter, with EPS growing +30.7% year-over-year.